Merck is the first drug manufacturer to announce it is issuing refunds to 340B providers in 2024.

Merck Offering Refunds to 340B Covered Entities

Drug manufacturer Merck recently announced that it owes refunds to 340B covered entities for purchases of 17 products during the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now.
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at